Neonc Technologies Holdings, Inc. operates as a high-burn, pre-commercial entity with no sustainable revenue stream, as evidenced by the lack of recurring income and a 2026Q1 cash balance of only $138,600. The company's reliance on aggressive R&D spending, whi...
Price trend, volume and key moving averages
Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 10, 2026 | -$0.58-397.1% vs -$0.12 | — vs — |
Q2 2026 May 18, 2026 | -$0.38-73.5% vs -$0.22 | — vs — |
Q2 2026 Mar 31, 2026 | -$0.40-7.3% vs -$0.37 | — vs — |
Q4 2025 Nov 14, 2025 | -$0.45-21.6% vs -$0.37 | — vs — |
Compassionate care for children in Abu Dhabi, a new research MoU and a senior banking appointment add momentum to NeOnc's development story Houston, Texas--(Newsfile Corp. - October 21, 2026) - As NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) prepares for an upcoming FDA meeting, its work in Abu Dhabi is bringing that human side of biotechnology into focus. Technology today can feel like magic.
DENVER, Oct. 21, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) — “I wish someone had told me about that company.” That is a familiar reaction when a stock attracts attention after investors have spent months overlooking it.
Proposed collaboration covers scientific exchange, specialist training and real-world evidence, alongside assessment of clinical trial opportunities and a potential regional presence for NeOnc in Abu Dhabi Two children in Abu Dhabi are receiving investigational NEO100 through NeOnc's Compassionate Care program, with a third expected this week CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 21, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced that it has signed a Memorandum of Understanding (MoU) with the Department of Health – Abu Dhabi (DoH) to cooperate on the development of research and clinical capability in oncology and central nervous system therapeutics in the Emirate of Abu Dhabi.
DENVER, Oct. 20, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- At an ugly-sweater party, the one with the most flair gets everyone talking. On Wall Street, attention can shift just as quickly when a battered chart meets a fresh set of corporate developments and an approaching regulatory milestone.
Benchmark NTHI against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Neonc Technologies Holdings, Inc. (NTHI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.03 | $78.57M | -0.94 | — | -155404.38% | — | — | |
| $14.17 | $1.64B | -11.61 | 8.28% | -21.25% | -44% | — | |
| $29.66 | $1.97B | -7.61 | -78.63% | -268385.71% | -52.36% | — | |
| $38.55 | $1.27B | -3.96 | -43.89% | -287.84% | -37.99% | — | |
| $29.42 | $6.07B | -10.62 | — | -7585.86% | -69.59% | — | |
| $286.35 | $505.92B | 120.82 | 8.57% | 9.81% | — | — |
Neonc Technologies Holdings, Inc. (NTHI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Neonc Technologies Holdings, Inc. (NTHI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 24, 2026·SEC
Apr 16, 2026·SEC
Apr 10, 2026·SEC
Mar 31, 2026·SEC
Get notified when NTHI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Neonc Technologies Holdings, Inc. (NTHI) stock FAQ — growth, dividends, profitability & financials explained
Neonc Technologies Holdings, Inc. (NTHI) reported $0.0M in revenue for fiscal year 2025.
Neonc Technologies Holdings, Inc. (NTHI) reported a net loss of $47.2M for fiscal year 2025.
Neonc Technologies Holdings, Inc. (NTHI) had negative free cash flow of $21.2M in fiscal year 2025, likely due to heavy capital investments.
